Archive for Month: July

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk

Background

Attention-deficit and hyperactivity disorder (ADHD) is frequently diagnosed in patients with substance use disorders (SUDs), including opioids. There remains concern about the safety and efficacy of prescription amphetamines (PAs) and their impact on effectiveness of opioid use disorder (OUD)...

Read More

Improving mental healthcare access and experience for people from minority ethnic groups: an England-wide multisite experience-based codesign (EBCD) study

Background

Long-standing ethnic inequalities in access and mental healthcare were worsened by the COVID-19 pandemic.

Objectives

Stakeholders coproduced local and national implementation plans to improve mental healthcare for people from minority ethnic groups.

Methods

Experience-based codesign conducted in four areas covered by National Health...

Read More